A Phase II Study of Gemcitabine in Combination with Tanespimycin in Advanced Epithelial Ovarian and Primary Peritoneal Carcinoma

OBJECTIVE: To evaluate the efficacy and biological effects of the gemcitabine/tanespimycin combination in patients with advanced ovarian and peritoneal cancer. To assess the effect of tanespimycin on tumor cells, levels of the chaperone proteins HSP90 and HSP70 were examined in peripheral blood mono...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Wahner Hendrickson, Andrea E., Oberg, Ann L., Glaser, Gretchen, Camoriano, John K., Peethambaram, Prema P., Colon-Otero, Gerardo, Erlichman, Charles, Ivy, Percy, Kaufmann, Scott H., Karnitz, Larry M., Haluska, Paul
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3265019/
https://ncbi.nlm.nih.gov/pubmed/22047770
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2011.10.002
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados